HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT05751850 · UNKNOWN
Trial details
- NCT number
- NCT05751850
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2024-12-30
- Enrollment
- 778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.